{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:40:19Z","timestamp":1793144419074,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.colsurfb.2025.114879","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T08:10:40Z","timestamp":1750061440000},"page":"114879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Oral formulations for cannabidiol: Improved absolute oral bioavailability of biodegradable cannabidiol self-emulsifying drug delivery systems"],"prefix":"10.1016","volume":"255","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6988-8015","authenticated-orcid":false,"given":"Matthias","family":"Sandmeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ee Tsin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte Nykj\u00e6r","family":"Nikolajsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asef","family":"Purwanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sera","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bernkop-Schn\u00fcrch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hoeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi Ziegler","family":"Bruun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne Skov","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2025.114879_bib1","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/cbdv.200790144","article-title":"History of cannabis and its preparations in saga, science, and sobriquet","volume":"4","author":"Russo","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.colsurfb.2025.114879_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/02791072.1981.10471447","article-title":"The religious and medicinal uses of cannabis in China, India and Tibet","volume":"13","author":"Touw","year":"1981","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.colsurfb.2025.114879_bib3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bcpt.13710","article-title":"A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)","volume":"130","author":"Peng","year":"2022","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"10.1016\/j.colsurfb.2025.114879_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s42238-023-00186-9","article-title":"The therapeutic potential of purified cannabidiol","volume":"5","author":"O\u2019Sullivan","year":"2023","journal-title":"J. Cannabis Res"},{"key":"10.1016\/j.colsurfb.2025.114879_bib5","series-title":"Prog Mol Biol Transl Sci","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.pmbts.2019.06.005","article-title":"Effects of cannabidiol (CBD) in neuropsychiatric disorders: a review of pre-clinical and clinical findings","author":"Elsaid","year":"2019"},{"key":"10.1016\/j.colsurfb.2025.114879_bib6","series-title":"Cannabinoids and Pain","author":"Narouze","year":"2021"},{"key":"10.1016\/j.colsurfb.2025.114879_bib7","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/epi.16597","article-title":"A perspective on the physicochemical and biopharmaceutic properties of marketed antiseizure drugs\u2014From phenobarbital to cenobamate and beyond","volume":"61","author":"Odi","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.colsurfb.2025.114879_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ph17020244","article-title":"Strategies to improve cannabidiol bioavailability and drug delivery","volume":"17","author":"O\u2019Sullivan","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.colsurfb.2025.114879_bib9","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/epi.16093","article-title":"Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy","volume":"60","author":"Birnbaum","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.colsurfb.2025.114879_bib10","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/jcph.1412","article-title":"A phase 1, Open-Label, Parallel-Group, Single-Dose trial of the pharmacokinetics and safety of cannabidiol (CBD) in subjects with mild to severe hepatic impairment","volume":"59","author":"Taylor","year":"2019","journal-title":"J. Clin. Pharm."},{"key":"10.1016\/j.colsurfb.2025.114879_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/epi.16419","article-title":"A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects","volume":"61","author":"Crockett","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.colsurfb.2025.114879_bib12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/17425247.2019.1653852","article-title":"A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed \/ fasting states","volume":"16","author":"Itin","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.colsurfb.2025.114879_bib13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00228-012-1393-4","article-title":"A phase I study to assess the effect of food on the single dose bioavailability of the THC\/CBD oromucosal spray","volume":"69","author":"Stott","year":"2013","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.colsurfb.2025.114879_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122651","article-title":"Oral lipid-based formulations alter delivery of cannabidiol to different anatomical regions in the brain","volume":"635","author":"Brookes","year":"2023","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.114879_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13091349","article-title":"Inclusion of medium-chain triglyceride in lipid-based formulation of cannabidiol facilitates micellar solubilization in vitro, but in vivo performance remains superior with pure sesame oil vehicle","volume":"13","author":"Feng","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.114879_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26051469","article-title":"Formulation of cannabidiol in colloidal lipid carriers","volume":"26","author":"Francke","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2025.114879_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106058","article-title":"Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol","volume":"168","author":"Kok","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2025.114879_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph13090219","article-title":"Towards better delivery of cannabidiol (Cbd)","volume":"13","author":"Millar","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.colsurfb.2025.114879_bib19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/cpdd.408","article-title":"Single-Dose pharmacokinetics of oral cannabidiol following administration of PTL101: a new formulation based on gelatin matrix pellets technology","volume":"7","author":"Atsmon","year":"2018","journal-title":"Clin. Pharm. Drug Dev."},{"key":"10.1016\/j.colsurfb.2025.114879_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2017.09.011","article-title":"Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration","volume":"266","author":"Cherniakov","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2025.114879_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24162967","article-title":"A novel self-emulsifying drug delivery system (SEDDS) based on Vesisorb\u00ae formulation technology improving the oral bioavailability of cannabidiol in healthy subjects","volume":"24","author":"Knaub","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2025.114879_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121159","article-title":"Lipid-based formulations to increase cannabidiol bioavailability: in vitro digestion tests, pre-clinical assessment and clinical trial","volume":"609","author":"De Pr\u00e1","year":"2021","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.114879_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3642418","article-title":"Preparation and evaluation of Solid-Self-Emulsifying drug delivery system containing paclitaxel for lymphatic delivery","volume":"2016","author":"Cho","year":"2016","journal-title":"J. Nanomater"},{"key":"10.1016\/j.colsurfb.2025.114879_bib24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1021\/js970300n","article-title":"Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor","volume":"87","author":"Hauss","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2025.114879_bib25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2018.10.014","article-title":"Successful development of oral SEDDS: screening of excipients from the industrial point of view","volume":"142","author":"Nardin","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2025.114879_bib26","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jcis.2024.07.233","article-title":"Oral formulations for highly lipophilic drugs: impact of surface decoration on the efficacy of self-emulsifying drug delivery systems","volume":"677","author":"Sandmeier","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.colsurfb.2025.114879_bib27","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2217\/nnm-2020-0127","article-title":"Cellular uptake of self-emulsifying drug-delivery systems: polyethylene glycol versus polyglycerol surface","volume":"15","author":"Friedl","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.colsurfb.2025.114879_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202307618","article-title":"Comparative analysis of PEG-Free and PEG-Based Self-Emulsifying drug delivery systems for enhanced oral bioavailability of therapeutic (Poly) peptides","author":"Haddadzadegan","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.colsurfb.2025.114879_bib29","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1039\/c3nr05559k","article-title":"Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells","volume":"6","author":"Pozzi","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.colsurfb.2025.114879_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jcis.2023.05.079","article-title":"PEG vs. Zwitterions: how these surface decorations determine cellular uptake of lipid-based nanocarriers","volume":"647","author":"Stengel","year":"2023","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.colsurfb.2025.114879_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123507","article-title":"Counterion optimization for hydrophobic ion pairing (HIP): unraveling the key factors","volume":"647","author":"Claus","year":"2023","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.114879_bib32","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1365-2621.1985.tb13006.x","article-title":"Relationship between functional (Fat Binding, Emulsifying) and physicochemical properties of muscle proteins. Effects of heating, freezing, ph and species","volume":"50","author":"LI-Chan","year":"1985","journal-title":"J. Food Sci."},{"key":"10.1016\/j.colsurfb.2025.114879_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejpb.2022.05.003","article-title":"Digestion of lipid excipients and lipid-based nanocarriers by pancreatic lipase and pancreatin","volume":"176","author":"Z\u00f6ller","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2025.114879_bib34","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1002\/jps.23757","article-title":"Development and evaluation of a novel mucus diffusion test system approved by self-nanoemulsifying drug delivery systems","volume":"102","author":"Friedl","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2025.114879_bib35","unstructured":"National Advisory Committee for Laboratory Animal Research, Guidelines on the Care and Use of Animals for Scientific Purposes, 2022.."},{"key":"10.1016\/j.colsurfb.2025.114879_bib36","unstructured":"Association for Assessment and Accreditation of Laboratory Animal Care International, Guide for the care and use of laboratory animals., 2011.."},{"key":"10.1016\/j.colsurfb.2025.114879_bib37","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bjp.2018.08.001","article-title":"Development and validation of reverse phase high performance liquid chromatography method for the determination of delta-9-tetrahydrocannabinol and cannabidiol in oromucosal spray from cannabis extract","volume":"28","author":"Saingam","year":"2018","journal-title":"Rev. Bras. De. Farmacogn."},{"key":"10.1016\/j.colsurfb.2025.114879_bib38","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/dta.2947","article-title":"A validated method for the simultaneous quantification of cannabidiol, \u0394 9 -tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open-label trial","volume":"13","author":"Kevin","year":"2021","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.colsurfb.2025.114879_bib39","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/smll.201201390","article-title":"Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking","volume":"9","author":"Duan","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.colsurfb.2025.114879_bib40","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/app.31207","article-title":"Influence of varying surface hydrophobicity of chitosan membranes on the adsorption and activity of lipase","volume":"115","author":"Deng","year":"2010","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.colsurfb.2025.114879_bib41","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1021\/acs.analchem.1c04172","article-title":"Quantitative determination of the hydrophobicity of nanoparticles","volume":"94","author":"Li","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.colsurfb.2025.114879_bib42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/can.2015.0012","article-title":"Human metabolites of cannabidiol: a review on their formation, biological activity, and relevance in therapy","volume":"1","author":"Ujv\u00e1ry","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.colsurfb.2025.114879_bib43","doi-asserted-by":"crossref","DOI":"10.1159\/000535726","article-title":"Pharmacokinetic variability of oral cannabidiol and its major metabolites after Short-Term High-Dose exposure in healthy subjects","volume":"7","author":"Zhang","year":"2024","journal-title":"Med Cannabis Cannabinoids"},{"key":"10.1016\/j.colsurfb.2025.114879_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124267","article-title":"Harnessing therapeutic deep eutectic solvents in self-emulsifying systems to improve CBD delivery","volume":"659","author":"Balenzano","year":"2024","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.114879_bib45","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejpb.2020.06.021","article-title":"Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers","volume":"154","author":"Izgelov","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2025.114879_bib46","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/epi4.12956","article-title":"Consensus panel recommendations for the optimization of EPIDIOLEX\u00ae treatment for seizures associated with Lennox\u2013Gastaut syndrome, dravet syndrome, and tuberous sclerosis complex","volume":"9","author":"Wechsler","year":"2024","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.colsurfb.2025.114879_bib47","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1021\/acs.molpharmaceut.0c00343","article-title":"Cosolvents in self-emulsifying drug delivery systems (SEDDS): do they really solve our solubility problems?","volume":"17","author":"J\u00f6rgensen","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2025.114879_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123534","article-title":"Self-emulsifying drug delivery systems (SEDDS): how organic solvent release governs the fate of their cargo","volume":"647","author":"J\u00f6rgensen","year":"2023","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.114879_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.61","article-title":"Shielding of lipid nanoparticles for siRNA delivery: impact on physicochemical properties, cytokine induction, and efficacy","volume":"3","author":"Kumar","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.colsurfb.2025.114879_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/ma501674x","article-title":"Rheological consequences of hydrogen bonding: linear viscoelastic response of linear polyglycerol and its permethylated analogues as a general model for hydroxyl-functional polymers","volume":"48","author":"Osterwinter","year":"2015","journal-title":"Macromolecules"},{"key":"10.1016\/j.colsurfb.2025.114879_bib51","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1021\/la300394c","article-title":"Investigation of the hydration of nonfouling material poly(sulfobetaine methacrylate) by low-field nuclear magnetic resonance","volume":"28","author":"Wu","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.colsurfb.2025.114879_bib52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0022-2275(20)39394-9","article-title":"Hydrolysis of fully esterified alcohols containing from one to eight hydroxyl groups by the lipolytic enzymes of rat pancreatic juice","volume":"13","author":"Mattson","year":"1972","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.colsurfb.2025.114879_bib53","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/0006-291X(76)90944-X","article-title":"Competitive inhibitory effect exerted by bile salt micelles on the mydrolysis of tributyrin by pancreatic lipase","volume":"69","author":"Vandermeers","year":"1976","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.colsurfb.2025.114879_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10620-006-9589-z","article-title":"Human pancreatic digestive enzymes","volume":"52","author":"Whitcomb","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.colsurfb.2025.114879_bib55","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0005-2744(68)90078-8","article-title":"Substrate specificity of pancreatic lipase","volume":"159","author":"Brockerhoff","year":"1968","journal-title":"Biochim. Et. Biophys. Acta (BBA) Enzymol."},{"key":"10.1016\/j.colsurfb.2025.114879_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1211\/0022357021771896","article-title":"Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products","volume":"54","author":"Sek","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.colsurfb.2025.114879_bib57","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bcpt.12342","article-title":"Mucus as a barrier to drug delivery - understanding and mimicking the barrier properties","volume":"116","author":"Boegh","year":"2015","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"10.1016\/j.colsurfb.2025.114879_bib58","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1021\/acs.molpharmaceut.0c00389","article-title":"Self-emulsifying drug delivery systems: hydrophobic drug polymer complexes provide a sustained release in vitro","volume":"17","author":"Bernkop-Schnurch","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2025.114879_bib59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijpharm.2018.01.018","article-title":"Self-emulsifying peptide drug delivery systems: how to make them highly mucus permeating","volume":"538","author":"Griesser","year":"2018","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.114879_bib60","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2018.12.048","article-title":"Highly mucus permeating and zeta potential changing self-emulsifying drug delivery systems: a potent gene delivery model for causal treatment of cystic fibrosis","volume":"557","author":"Griesser","year":"2019","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.114879_bib61","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.colsurfb.2025.114879_bib62","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.colsurfb.2015.07.038","article-title":"The influence of small intestinal mucus structure on particle transport ex vivo","volume":"135","author":"Bajka","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2025.114879_bib63","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1021\/acsnano.2c11147","article-title":"Mucus penetration of Surface-Engineered nanoparticles in various ph microenvironments","volume":"17","author":"Guo","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2025.114879_bib64","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1517\/17425255.4.1.65","article-title":"In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability","volume":"4","author":"Fatouros","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.colsurfb.2025.114879_bib65","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijpharm.2011.03.002","article-title":"In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems","volume":"417","author":"Larsen","year":"2011","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.114879_bib66","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s40262-020-00931-w","article-title":"The interplay between liver First-Pass effect and lymphatic absorption of cannabidiol and its implications for cannabidiol oral formulations","volume":"59","author":"Franco","year":"2020","journal-title":"Clin. Pharm."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525003868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525003868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:20:28Z","timestamp":1762330828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776525003868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":66,"alternative-id":["S0927776525003868"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.114879","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral formulations for cannabidiol: Improved absolute oral bioavailability of biodegradable cannabidiol self-emulsifying drug delivery systems","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.114879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114879"}}